Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
The Evolution of T-cell Therapies for Solid MalignanciesKristen Fousek, Nabil Ahmed
The FEBS Journal|May 1, 2012
Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancerMin Guan, Kristen Fousek, Warren A Chow
Trends in Cancer|April 30, 2020
Tumor Plasticity and Resistance to ImmunotherapyLucas A Horn, Kristen Fousek, Claudia Palena
Pharmacology & Therapeutics|September 27, 2020
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppressionKristen Fousek, Lucas A Horn, Claudia Palena
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6Min Guan, Kristen Fousek, Chunling Jiang, et al.
Journal for Immunotherapy of Cancer|September 7, 2023
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysisMadeline Dahut, Kristen Fousek, Lucas A Horn, et al.
Cancers|March 6, 2021
Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination ImmunotherapyLucas A Horn, Kristen Fousek, Duane H Hamilton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 21, 2022
An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLCKristen Fousek, Lucas A Horn, Haiyan Qin, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2012
Phase I study of nelfinavir in liposarcomaJanet Pan, Michelle Mott, Bixin Xi, et al.
The Journal of Clinical Investigation|March 1, 2022
Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1-mediated tumor eradicationLucas A Horn, Paul L Chariou, Sofia R Gameiro, et al.
Pageof 3